Walleye Trading LLC Kala Pharmaceuticals, Inc. Transaction History

Walleye Trading LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.74 $7,932 - $18,736	-6,838 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.62 - $5.43 $57,372 - $118,906	-21,898 Reduced 76.2%	6,838 $18,000
Q2 2021 Aug 16, 2021	BUY	$5.06 - $8.15 $115,231 - $185,599	22,773 Added 381.91%	28,736 $152,000
Q4 2020 Feb 16, 2021	BUY	$6.28 - $8.79 $37,447 - $52,414	5,963 New	5,963 $40,000
Q3 2020 Nov 16, 2020	SELL	$7.5 - $11.11 $213,217 - $315,846	-28,429 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$8.33 - $13.79 $236,813 - $392,035	28,429 New	28,429 $299,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $8.67M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.